Inhibition by somatostatin of bovine growth hormone secretion following sodium channel activation.
- 30 June 1981
- journal article
- research article
- Published by Wiley in The Journal of Physiology
- Vol. 316 (1) , 85-96
- https://doi.org/10.1113/jphysiol.1981.sp013774
Abstract
Growth hormone secretion, exchangeable cellular Na and Ca concentrations measured by 22Na and 45Ca incorporation, and efflux of 45Ca were studied in dispersed bovine anterior pituitary cells. Addition of veratridine (100 .mu.M), an activator of Na channels, increased exchangeable Na and Ca concentrations in the cells, the efflux of 45Ca from prelabelled cells, and caused a biphasic stimulation of the rate of growth hormone secretion. Secretion of growth hormone was not stimulated when the extracellular Ca was decreased < 0.1 mM. The increases in growth hormone secretion, exchangeable Ca concentration and 45Ca efflux from prelabelled cells caused by veratridine were abolished by addition of the Ca antagonist verapamil (20 .mu.M). Verapamil also reduced the rise in exchangeable Na caused by veratridine and increased the resting exchangeable Na concentrations. The peptide somatostatin (1 .mu.g/ml) prevented veratridine-stimulated growth hormone secretion but did not inhibit the increases in exchangeable Na and Ca caused by veratridine. The peptide itself elicited a transient increase in 45Ca efflux and subsequently partially inhibited veratridine-stimulated 45Ca efflux. Anterior pituitary cells probably possess voltage-sensitive Na channels. Activation of these channels by veratridine may lead to depolarization and increased entry of Ca via potential-dependent Ca channels, which contributes to a rise in cytoplasmic Ca concentration and the subsequent stimulation of growth hormone secretion. The Ca antagonist verapamil may also interact with Na channels, and the peptide somatostatin may act on growth-hormone-secreting cells either to prevent the rise in cytoplasmic Ca by hyperpolarizing the cells or to decrease the affinity of a population of Ca binding sites in the cells.This publication has 34 references indexed in Scilit:
- THE EFFECT OF VERATRIDINE ON THE RELEASE OF CATECHOLAMINES FROM THE PERFUSED ADRENAL GLANDBritish Journal of Pharmacology, 1979
- Effects of veratridine on Ca fluxes and the release of oxytocin and vasopressin from the isolated rat neurohypophysis.The Journal of general physiology, 1978
- Sodium and calcium action potential in pituitary cellsNature, 1977
- Reversal of somatostatin inhibition of insulin secretion by calciumBiochemical and Biophysical Research Communications, 1974
- Somatostatin inhibition of rat growth hormone release in vitro in the presence of BaCl2or 3-isobutyl-1-methylxanthineFEBS Letters, 1974
- Inhibition of adenosine 3′,5′-monophosphate accumulation in anterior pituitary gland in vitro by growth hormone-release inhibiting hormoneBiochemical and Biophysical Research Communications, 1974
- Differentiation of the transmembrane Na and Ca channels in mammalian cardiac fibres by the use of specific inhibitorsPflügers Archiv - European Journal of Physiology, 1972
- Effects of various secretagogues upon 42K and 22Na uptake during in vitro hormone release from the rat adenohypophysis
- The effect of veratridine on excitable membranes of nerve and muscleErgebnisse der Physiologie, Biologischen Chemie und Experimentellen Pharmakologie, 1968
- ATP-dependent Ca++-Extrusion from human red cellsCellular and Molecular Life Sciences, 1966